Transaction · 0001213900-26-060632

Zhai Yifan

Zhai Yifan, CMO, reported a transaction classified as grant at ASCENTAGE PHARMA GROUP INTERNATIONAL involving 214999.000000 shares for an estimated $0.00. Reported holdings after the transaction were 214999.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACMO

AAPGASCENTAGE PHARMA GROUP INTERNATIONAL

Trade date: May 20, 2026
Filing date: May 22, 2026

View on SEC Insider profile

Disclosed value$0Shares × reported price

Shares traded214k$0.00 per share

Holdings after214kDirect

% of reported position tradedUnavailableThis security and ownership context

How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

AAPG price since this filing

Daily closing prices, with the filing date and available return windows

AAPG · Daily closing priceLoading daily prices…

Filing dateReturn windows appear as prices become available.

Pre-filing1mo ago +25.5%1w ago +1.8%1d ago -9.6%

Returns since7d -4.8%30d -18.5%90d -17.6%180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative

Type: grant
Identifier: 0001213900-26-060632
Transaction date: May 20, 2026
Shares: 214,999 sh
Estimated value: $0
Holdings after: 214,999 sh

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M

Derivative Transaction Direct Ownership Large Holdings Increase

Filing-only score

-6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated

direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake.
timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction.
derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.

Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Medical Officer

Officer YesDirector No10% NoOther No

Footnotes & amended

F1F2F3(3 footnotes)
Shares held by Dajun Yang Dynasty Trust, of which the Reporting Person's spouse is the investment advisor. The Reporting Person disclaims beneficial ownership over such securities except to the extent…
F4
Each restricted stock unit (the "RSUs") represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on November 26, 2026, 2027, 2028…
F5
The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date.
F6
The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal…
F7
The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal…
F8
The RSUs vested on 05/21/2026 and had no expiration date.
F9
Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026.
F10
Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person's spouse on 05/20/2026.

Original filing · 0001213900-26-060632

Related transactions

0 other transactions

Same SEC filing

Recent company activity

0 recent txs

AAPG